Neuraxial infusion in the management of cancer pain.
Pain due to malignancy can be controlled through simple means in most patients. In certain refractory cases, however, the chronic delivery of analgesics to the epidural or subarachnoid space may be appropriate. This review will discuss criteria for patient selection for neuraxial drug delivery, the technologic systems available for neuraxial drug delivery, and criteria for selection of the appropriate technology in the individual patient.
Ferrante
F M
FM
Anesthesia Pain Medicine Center, University of Pennsylvania, School of Medicine, Philadelphia, USA.
D000700:Analgesics / Q000008:administration & dosage*; D002404:Catheterization; D003362:Cost-Benefit Analysis; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D015918:Infusion Pumps, Implantable; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy*; D019736:Prostheses and Implants; D012307:Risk Factors
D000700:Analgesics